Morgan’s had a fair value of $10 for APO 2 years ago. Go figure....

First 2 Last

Share
Profile

Follow
mrcarter

507 Posts.

23/01/18

12:16

Post #: 30496222
Share

Originally posted by williak ↑

DHG - DOMAIN HOLDINGS AUSTRALIA LIMITED

Morgan Stanley rates DHG as Overweight (1) - The resignation of CEO Anthony Catalano is an incremental negative for the shares and a surprise to Morgan Stanley, coming less than three months after the company's IPO. The departure creates uncertainty over strategy and growth aspirations, the broker acknowledges.

Separately, the company has confirmed first half revenue growth of 13% including digital revenue growth of 22% which is in line with the broker's expectations.

Overweight rating and a $4.50 target. Industry View is Attractive.
Target price is $4.50 Current Price is $2.75 Difference: $1.75 If DHG meets the Morgan Stanley target it will return approximately 64% (excluding dividends, fees and charges). Current consensus price target is $3.42, suggesting upside of 24.5%(ex-dividends)The company's fiscal year ends in June.
Forecast for FY18:
Morgan Stanley forecasts a full year FY18 dividend of 4.40 cents and EPS of 9.00 cents .At the last closing share price the estimated dividend yield is 1.60%. At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 30.56. How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 8.8, implying annual growth of N/A.Current consensus DPS estimate is 3.7, implying a prospective dividend yield of 1.3%.Current consensus EPS estimate suggests the PER is 31.2.Forecast for FY19:
Morgan Stanley forecasts a full year FY19 dividend of 5.90 cents and EPS of 12.00 cents .At the last closing share price the estimated dividend yield is 2.15%. At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 22.92. How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 11.3, implying annual growth of 28.4%.Current consensus DPS estimate is 4.8, implying a prospective dividend yield of 1.7%.Current consensus EPS estimate suggests the PER is 24.3.
Market Sentiment: -0.1All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

Expand

Morgan’s had a fair value of $10 for APO 2 years ago. Go figure.

Never trust these son biches

DHG Price at posting: $3.00 Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

ASX Market Open: Rising Aussie markets to ignore Wall Street's Thanksgiving caution | November 28, 2024

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

ACW

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

First 2 Last

Add DHG (ASX) to my watchlist

(20min delay)
Last $2.88		Change 0.000(0.00%)		Mkt cap ! $1.806B

Open	High	Low	Value	Volume
$2.89	$2.90	$2.86	$575.9K	200.3K

Buyers (Bids)

No.	Vol.	Price($)
3	4157	$2.86

Sellers (Offers)

Price($)	Vol.	No.
$2.89	4157	3

View Market Depth

No.	Vol.	Price($)
6	10912	2.780
1	4149	2.770
4	21265	2.760
1	1158	2.750
2	3058	2.740

Price($)	Vol.	No.
2.810	4149	1
2.820	5307	2
2.830	5307	3
2.840	1158	1
2.850	1158	1

Last trade - 16.10pm 27/11/2024 (20 minute delay)

DHG (ASX) Chart

Morgan’s had a fair value of $10 for APO 2 years ago. Go figure....

Top Stories

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

ASX Market Open: Rising Aussie markets to ignore Wall Street's Thanksgiving caution | November 28, 2024

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

Buyers (Bids)

Sellers (Offers)